Stifel Nicolaus Increases Astrana Health (NASDAQ:ASTH) Price Target to $48.00

Astrana Health (NASDAQ:ASTH) had its price target raised by Stifel Nicolaus from $45.00 to $48.00 in a report issued on Thursday morning, Benzinga reports. They currently have a buy rating on the stock.

Other research analysts have also issued reports about the company. Robert W. Baird began coverage on Astrana Health in a report on Thursday, May 30th. They set an outperform rating and a $54.00 price target for the company. Truist Financial boosted their price objective on Astrana Health from $41.00 to $44.00 and gave the company a hold rating in a research report on Friday, March 1st. Finally, Baird R W upgraded Astrana Health to a strong-buy rating in a research report on Thursday, May 30th. One investment analyst has rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of Buy and an average price target of $49.00.

Astrana Health Stock Down 0.5 %

Shares of ASTH stock opened at $40.56 on Thursday. Astrana Health has a 12 month low of $28.86 and a 12 month high of $45.71. The firm has a market capitalization of $2.27 billion, a price-to-earnings ratio of 30.73, a PEG ratio of 1.45 and a beta of 1.12. The stock’s 50 day simple moving average is $39.48. The company has a current ratio of 1.52, a quick ratio of 1.52 and a debt-to-equity ratio of 0.56.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.31 EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). Astrana Health had a return on equity of 10.22% and a net margin of 4.29%. The business had revenue of $404.36 million for the quarter, compared to analyst estimates of $413.84 million. During the same quarter last year, the firm earned $0.42 earnings per share. The firm’s quarterly revenue was up 19.9% compared to the same quarter last year. As a group, equities analysts predict that Astrana Health will post 1.41 EPS for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.